Higher, faster isn’t the goal. Getting there right is.

The manufacturers write a titration schedule built to get every patient to a high dose on a fixed calendar — four weeks here, four weeks there, moving up whether the current dose is still working or not. Summit runs a different protocol. Below is exactly how it works, in the same numbers Dr. Miranda actually uses in the chart.

Two schedules, side by side

The chart below plots the FDA-approved label schedule for tirzepatide (the active ingredient in Zepbound® and Mounjaro®) against Summit’s own internal protocol, SOP-003. Both lines represent the fastest each approach allows — but only one of them is actually gated by whether the drug is still doing its job.

How to read this: the FDA line is a calendar — it moves every 4 weeks whether or not the drug is still working, and reaches its ceiling by roughly week 20 for anyone who tolerates it. Summit’s line only moves once your own weight loss has actually plateaued, and in Dr. Miranda’s practice that typically takes 8 to 12 weeks per dose — not 4. The practical result: most Summit patients are still in the low-to-mid dose range around the point the FDA schedule has already maxed out, and don’t reach the 14mg ceiling until nearly a year in, if ever. Sources: Zepbound® (tirzepatide) FDA Prescribing Information, Eli Lilly and Company; Summit Metabolic Health SOP-003 Dosing Escalation Protocol v4.0 (May 2026), applied at Dr. Miranda’s real-world pace.

What this actually costs, over the same timeline

Slower, lower doses aren’t just gentler — they’re dramatically cheaper, because compounded medication is priced by the milligram. Here’s the same 56-week timeline, this time plotted as what you’d actually pay each month.

How to read this: this plots what you’d actually be billed each month, at whatever dose the timeline above has you on. Zepbound’s self-pay price is tied to dose only up to a point — every dose from 7.5mg to the 15mg ceiling costs the same $449/mo, so brand-name cost maxes out fast and stays there for the rest of treatment. Summit’s compounded cost scales directly and only with your actual mg — $5 per mg on top of the flat $149 program fee — so even at Summit’s own 14mg ceiling, the total is less than half of Zepbound’s self-pay rate. Sources: LillyDirect Zepbound self-pay vial pricing (Eli Lilly and Company, verified August 2026: $299/2.5mg, $399/5mg, $449/7.5–15mg with on-time refill); Summit Metabolic Health program pricing and Aspire Pharmacy pass-through rate, confirmed by Dr. Miranda.

What actually decides when you move up

Summit’s written protocol is one sentence: escalate only after weight loss has stalled at the current dose. Not a calendar date. Not a fixed number of vials used. A real, observed plateau. In Dr. Miranda’s actual practice, confirming that a plateau is real — not just a slow week — typically takes 8 to 12 weeks, not the 4 weeks a fixed schedule would assume. Every dose change happens at a completed monthly visit — in-office, in-home, or via telehealth — where Dr. Miranda reviews how you’ve actually responded before deciding whether to hold or advance. Prescriptions are sent to Aspire Pharmacy, an independent 503A compounding pharmacy, only after that decision is made.

What each phase actually feels like

Onboarding (2–6mg): this is where your body adjusts — appetite changes, GI tolerance, injection routine. Doses here exist to get you tolerating the medication cleanly, not to drive maximum loss yet.

Active phase (8–12mg): this is where most of Summit’s patients do the majority of their fat loss. It’s also where Dr. Miranda expects to spend the most real-world time, because this is the range most likely to keep working at the same dose for months without needing to go higher.

14mg (ceiling): used sparingly, and only if loss has genuinely stalled at 12mg for 8–12 weeks. Many patients never need it — reaching your goal at a lower dose is a better outcome under this protocol, not a lesser one.

The built-in brakes

Escalation isn’t the only decision this protocol makes — it also defines exactly when to stop increasing, or back off:

• Hold the dose if nausea reaches a grade that interferes with daily function, if vomiting happens more than twice a week, if appetite suppression is cutting into your protein intake, or if you simply ask for a slower pace — that request is always honored.
• Reduce the dose if grade-2+ GI symptoms persist more than two weeks at the current dose, or if you’re losing more than 2 lbs a week in a way that raises concern for muscle loss rather than fat loss — in that case the plan shifts toward protein intake and strength training before the dose goes any further.

What Summit actually monitors, and when

Past six months on tirzepatide, Dr. Miranda’s protocol calls for lab monitoring of iron, B12, vitamin D, calcium, magnesium, zinc, thiamine, and folate — nutrients GLP-1/GIP therapy can quietly deplete as appetite and intake both drop over a long course of treatment. This isn’t a hypothetical — it’s a standing part of the protocol precisely because slow, extended therapy means more months where those levels need watching.

The same philosophy, on semaglutide

Patients on compounded semaglutide instead of tirzepatide follow the identical rule, on a different dose ladder:

Same rule, same philosophy, different molecule: escalate only after a real stall, never on a fixed calendar. Source: Summit Metabolic Health SOP-003 Dosing Escalation Protocol v4.0.